AI assistant
GILEAD SCIENCES, INC. — Director's Dealing 2019
Feb 8, 2019
29828_dirs_2019-02-08_7eb7c11f-1fb0-469d-995e-03478cff87b7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2019-02-06
Reporting Person: MARTIN JOHN C (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-02-06 | Common Stock | A | 7745 | — | Acquired | 2885507 | Direct |
| 2019-02-06 | Common Stock | A | 15505 | — | Acquired | 2901012 | Direct |
| 2019-02-06 | Common Stock | F | 13787 | $68.75 | Disposed | 2887225 | Direct |
Footnotes
F1: Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on February 2, 2017. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors. However, the shares will not be issued to the Reporting Person until such individual upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors.
F2: Represents shares of the Issuer's common stock subject to specific tranches of the performance share award made to the Reporting Person on February 1, 2016. Such tranches of shares were subject to performance-vesting and service-vesting requirements and became issuable on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation Committee of the Issuer's Board of Directors.